News All News

From the labs of Pam Silver, Elliot T. and Onie H. Adams Professor of Biochemistry and Systems Biology at Harvard Medical School (HMS) and Wyss Institute Core Faculty member, and Michael Springer, Professor of Systems Biology at HMS and Wyss Institute Associate Faculty member, a research team led by Neil Dalvie, a Fellow in Systems Biology at HMS, is developing a technology that uses engineered bacterial strains to accelerate mineral weathering. The research was supported by Harvard's Climate and Sustainability Translational Fund.

Harvard Magazine’s Q&A with Leonardo Riella, the HMS Harold and Ellen Danser Associate Professor of Surgery at Massachusetts General Hospital, on the advancement of xenotransplantation. Reilla discusses what the research and medical teams learned from the first successful kidney transplant using a genetically engineered pig kidney developed by eGenesis, a company founded by HMS Professor George Church and former HMS postdoctoral fellow Luhan Yang with support from the Wyss Institute.

Connie Cepko reflects on four decades of advancing efforts to prevent or treat vision-threatening disease. The Cepko Lab is highly translational, advancing research with support from the Blavatnik Biomedical Accelerator and by collaborating with industry, resulting in over 40 inventions from the lab.

Harvard University has expanded a research alliance agreement with Northpond Labs to fund translational research, accelerate commercialization, and advance breakthrough healthcare innovations across Harvard labs at the Wyss Institute, Harvard Medical School, John A. Paulson School of Engineering and Applied Sciences, and Faculty of Arts and Sciences.